RARA CRAFT DATABASE for FDA Medical Devices
510(k)K201592

FDA DEVICE FACTS

Cardinal Health Protexis PI Blue with Neu-Thera Surgical Glove

Cardinal Health200, LLC

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATESeptember 26, 2021PRODUCT CODEKGO

Indications for use

Cardinal Health™ Protexis™ PI Blue with Neu-Thera™ Surgical Gloves are powder-free surgeon's gloves that are disposable devices made of synthetic rubber intended to b e worn by operating room personnel to protect a surgical wound from contamination. In addition, these gloves have been tested for resistance to permeation of vario us chemotherapy drugs per ASTM D6978, “Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs.” Chemotherapy Drug Permeation Resistance (minimum breakthrough detection time in minutes , 0.01 μg/cm2/min): Carmustine............................................................................ (3.3 mg/mL) 18.5 Cisplatin ................................................................................... (1 mg/mL) >240 Cyclophosphamide ...... ......................................................... (20 mg/mL) >240 Doxorubicin Hydrochloride.................................................... (2 mg/mL) >240 Etoposide................................................................................ (20 mg/mL) >240 5-Fluorouracil........................................................................ (50 mg/mL) >240 Methotrexate ........................................................................ (25 mg/mL) >240 Mitomycin C .......................................................................... (0.5 mg/mL) >240 Paclitaxel ................................................................................. (6 m g/mL) >240 Thiotepa ................................................................................ (10 mg/mL) 24.4 Vincristine Sulfate .................................................................. (1 mg/mL) >240 P lease note that the gloves showed extremely low permeation times of 18.5 and 24.4 minutes respectively with Carmustine (BCNU) (3.3 mg/mL) and Thiotepa (10 mg/ mL). When chemotherapy drugs are present, gloves selection should be based on the specific type(s) of chemicals used. Users are recommended to review drug labeling or material safety data sheets for the chemicals being used to determine an adequate level o f protection.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 23, 2026